Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cardiology|January 1, 1993
Development of a multiaction beta blocker. Scientific challenges and regulatory needsJ N Lessem, M A LukasThe American Journal of Cardiology|October 29, 2000
Effect of concomitant digoxin and carvedilol therapy on mortality and morbidity in patients with chronic heart failureE J Eichhorn, M A Lukas, B Wu, et al.Biochemistry|January 8, 2000
Evaluation of the affinity and turnover number of both hepatic mitochondrial and microsomal carnitine acyltransferases: relevance to intracellular partitioning of acyl-CoAsK A Abo-Hashema, M H Cake, M A Lukas, et al.The International Journal of Biochemistry & Cell Biology|June 19, 2001
The interaction of acyl-CoA with acyl-CoA binding protein and carnitine palmitoyltransferase IK A Abo-Hashema, M H Cake, M A Lukas, et al.Journal of Human Hypertension|February 1, 1993
Preclinical and clinical pharmacology of carvedilolR R Ruffolo, D A Boyle, R P Venuti, et al.Pharmacology|February 19, 1998
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heartR N Willette, M P Mitchell, E H Ohlstein, et al.The American Journal of Cardiology|October 30, 1998
Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study GroupR Weiss, D Ferry, E Pickering, et al.Journal of Cardiac Failure|September 21, 2000
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant PhysiciansJ A Franciosa, W T Abraham, M Fowler, et al.The New England Journal of Medicine|May 3, 2001
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failureC W Yancy, M B Fowler, W S Colucci, et al.Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.Pageof 2